Evidence map›Paper›PMID 40481533›Full record

ArticleOrphanet journal of rare diseases2025

The association of body image with quality of life, psychological assistance and social support in neurofibromatosis type 1 patients: a cross-sectional study.

Daniel Muñoz, Mercè Jodar, Laia Valls, Albert Fornieles-Deu, Elisabeth Castellanos, Ignacio Blanco

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel MuñozClinical and Health Psychology Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0009-0001-8816-8283
Mercè JodarClinical and Health Psychology Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8913-5977
Laia VallsClinical Genomics Group, CARE Program, Institut d'investigació Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.
Albert Fornieles-DeuDepartment of Psychobiology and Methodology of Health Sciences, Serra Húnter Fellow, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7944-7328
Elisabeth CastellanosClinical Genomics Group, CARE Program, Institut d'investigació Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8133-5325
Ignacio BlancoClinical Genomics Group, CARE Program, Institut d'investigació Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain. iblanco.germanstrias@gencat.cat.ORCID http://orcid.org/0000-0002-7414-7481

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca SGR-Cat 2021-00967Fundació la Marató de TV3 126/C/2020Instituto de Salud Carlos III PI23/00619
6 · The paper itself

Abstract

backgroundNeurofibromatosis type 1 is a genetic disease with an autosomal dominant pattern. One of its clinical features is the presence of disfiguring neurofibromas. Most adults with Neurofibromatosis type 1 have visible neurofibromas depending on the severity of their skin related clinic that can affect their body image, and body image influencing psychological assistance and social support. This research explored Body image, the negative perception of the appearance of neurofibromas and skin severity in Neurofibromatosis type 1 patients; assessed its association with quality of life; and the role of social support and psychological assistance.

resultsTwo hundred five patients with Neurofibromatosis type 1 (16-74 years) were included in the study. They responded to questionnaires about their quality of life, body image and other sociodemographic data. Correlations and simple and multiple regressions were used to assess the relationships between variables. The results showed that body image problems increased if Neurofibromatosis type 1 patients were concerned about the aspects of their neurofibromas (B = 4.544; p < 0.001) and if they had severe skin conditions (B = 4.262; p < .001). Despite this, statistical analysis showed that only body image impairments reduced quality of life by 0.605 (p < 0.001), while skin severity and the negative perception of the appearance of neurofibromas were not clearly related. Patients with body image impairments are more likely to seek psychological assistance (ρ = 0.218; p < 0.01), but they are less likely to report having social support. The results also showed that when patients with Neurofibromatosis type 1 retrieved they have social support (ρ = -0.210, p < 0.01) or they inform doing psychological assistance (ρ = -0.238; p < 0.001), they have lower quality of life.

conclusionBody image concerns, rather than skin severity, are a key feature for detecting quality of life impairments in these patients. When healthcare professionals detect body image impairments, it is crucial for them to collaborate with patients and either provide or refer them to psychological interventions. This approach helps improve social support, enabling patients to benefit from both their professional and personal environments.

Indexed as

Body ImageNeurofibromatosis 1Quality of LifeSocial SupportAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultBody imagePsychological assistanceQuality of lifeRare diseaseSkin severitySocial supportSources of support

Identifiers

PMID40481533
PMCPMC12143036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.